{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:24:12Z","timestamp":1787739852684,"version":"build-2784847793"},"reference-count":229,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"National Cancer Institute, Center for Cancer Research","award":["ZIABC012091"],"award-info":[{"award-number":["ZIABC012091"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bladder Cancer"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Alterations in mRNA splicing play a critical role in driving the molecular heterogeneity of many cancers, including urothelial carcinoma, by contributing to disease progression, treatment response, and clinical outcomes. These splicing changes can arise from somatic mutations in core spliceosomal components or through alternative splicing events affecting cancer-associated genes. In this review, we examine how dysregulation of pre-mRNA splicing influences key aspects of urothelial carcinoma biology, including cell proliferation, invasion, metastasis, modulation of the immune microenvironment, metabolism, and therapeutic resistance. We highlight frequently observed splicing-factor mutations and discuss the impact of aberrant splicing and cancer-specific isoforms on prognosis. We also explore splicing alterations associated with susceptibility to urothelial carcinoma and review emerging therapeutic strategies, such as splice-switching oligonucleotides and small molecule spliceosome inhibitors, that offer promising avenues for precision medicine in this disease.<\/jats:p>","DOI":"10.1177\/23523735251389276","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:04:29Z","timestamp":1761581069000},"source":"Crossref","is-referenced-by-count":3,"title":["Dysregulation of mRNA splicing in urothelial carcinoma: Clinical, diagnostic and therapeutic implications"],"prefix":"10.1177","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4134-6054","authenticated-orcid":false,"given":"Rod Carlo A","family":"Columbres","sequence":"first","affiliation":[{"name":"National Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea B","family":"Apolo","sequence":"additional","affiliation":[{"name":"National Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-340X","authenticated-orcid":false,"given":"A","family":"Rouf Banday","sequence":"additional","affiliation":[{"name":"National Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.007"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1330"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103283"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.51"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081200"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.01.088"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.08.006"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10615"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.09.053"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.08.036"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.367"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.11.002"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-234"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3850"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087361"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12634"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.08.018"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.181016.114"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00202-15"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00338"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413298"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1412811112"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.100354"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2816"},{"key":"e_1_3_3_27_2","article-title":"Fibroblast growth factor receptors-1 and \u22123 play distinct roles in the regulation of bladder cancer growth and metastasis: implications for therapeutic targeting","volume":"8","author":"Cheng T","year":"2013","unstructured":"Cheng T, Roth B, Choi W, et al. Fibroblast growth factor receptors-1 and \u22123 play distinct roles in the regulation of bladder cancer growth and metastasis: implications for therapeutic targeting. PloS One 2013; 8: e57284.","journal-title":"PloS One"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds486"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-007-0213-4"},{"key":"e_1_3_3_30_2","first-page":"08","article-title":"Analysis of FGFR3 and HRAS genes in patients with bladder cancer","volume":"34","author":"Homami A","year":"2020","unstructured":"Homami A, Ataei Kachoei Z, Asgarie M, et al. Analysis of FGFR3 and HRAS genes in patients with bladder cancer. Med J Islam Repub Iran 2020; 34: 08.","journal-title":"Med J Islam Repub Iran"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1718"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.11.012"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203186"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2044"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.100354"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20547"},{"key":"e_1_3_3_37_2","first-page":"1005","article-title":"Alternate splicing produces a novel cyclin D1 transcript","volume":"11","author":"Betticher DC","year":"1995","unstructured":"Betticher DC, Thatcher N, Altermatt HJ, et al. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995; 11: 1005\u20131011.","journal-title":"Oncogene"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)62960-4"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21795"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12165"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.67409"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0664-7"},{"key":"e_1_3_3_43_2","first-page":"873","article-title":"Progressive loss of CD44 gene expression in invasive bladder cancer","volume":"149","author":"Sugino T","year":"1996","unstructured":"Sugino T, Gorham H, Yoshida K, et al. Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol 1996; 149: 873\u2013882.","journal-title":"Am J Pathol"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.5061"},{"key":"e_1_3_3_45_2","article-title":"Transcriptome profiling of a multiple recurrent muscle-invasive urothelial carcinoma of the bladder by deep sequencing","volume":"9","author":"Zhang S","year":"2014","unstructured":"Zhang S, Liu Y, Liu Z, et al. Transcriptome profiling of a multiple recurrent muscle-invasive urothelial carcinoma of the bladder by deep sequencing. Plos One 2014; 9: e91466.","journal-title":"Plos One"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65282-2"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000129541.23460.48"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.39"},{"key":"e_1_3_3_49_2","first-page":"825","article-title":"Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis","volume":"14","author":"Schlott T","year":"2004","unstructured":"Schlott T, Quentin T, Korabiowska M, et al. Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis. Int J Mol Med 2004; 14: 825\u2013836.","journal-title":"Int J Mol Med"},{"key":"e_1_3_3_50_2","first-page":"161","article-title":"Role of alternative splicing of periostin in human bladder carcinogenesis","volume":"32","author":"Kim CJ","year":"2008","unstructured":"Kim CJ, Isono T, Tambe Y, et al. Role of alternative splicing of periostin in human bladder carcinogenesis. Int J Oncol 2008; 32: 161\u2013169.","journal-title":"Int J Oncol"},{"key":"e_1_3_3_51_2","first-page":"3370","article-title":"Frequent alteration of p63 expression in human primary bladder carcinomas","volume":"60","author":"Park BJ","year":"2000","unstructured":"Park BJ, Lee SJ, Kim JI, et al. Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 2000; 60: 3370\u20133374.","journal-title":"Cancer Res"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80275-0"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2010.11.061"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1188"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-012-0082-8"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.4161\/cc.21400"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-017-0032-5"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00352.2010"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1999.5790"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-022-10048-0"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M700590-MCP200"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(92)90285-B"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006039"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020307"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.4161\/cc.21852"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1078-1439(00)00130-7"},{"key":"e_1_3_3_67_2","first-page":"1","article-title":"Aberrant cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation","volume":"14","author":"Wang J","year":"2023","unstructured":"Wang J, Su W, Zhang T, et al. Aberrant cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis 2023; 14: 1\u201317.","journal-title":"Cell Death Dis"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21120"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0798-839"},{"key":"e_1_3_3_70_2","first-page":"4165","article-title":"Mutational analysis of the p63\/p73L\/p51\/p40\/CUSP\/KET gene in human cancer cell lines using intronic primers","volume":"59","author":"Hagiwara K","year":"1999","unstructured":"Hagiwara K, McMenamin MG, Miura K, et al. Mutational analysis of the p63\/p73L\/p51\/p40\/CUSP\/KET gene in human cancer cell lines using intronic primers. Cancer Res 1999; 59: 4165\u20134169.","journal-title":"Cancer Res"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202474"},{"key":"e_1_3_3_72_2","first-page":"2791","article-title":"Elevated and biallelic expression of p73 is associated with progression of human bladder cancer","volume":"59","author":"Chi SG","year":"1999","unstructured":"Chi SG, Chang SG, Lee SJ, et al. Elevated and biallelic expression of p73 is associated with progression of human bladder cancer. Cancer Res 1999; 59: 2791\u20132793.","journal-title":"Cancer Res"},{"key":"e_1_3_3_73_2","first-page":"5642","article-title":"P73 expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer","volume":"9","author":"Puig P","year":"2003","unstructured":"Puig P, Capodieci P, Drobnjak M, et al. P73 expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer. Clin Cancer Res Off J Am Assoc Cancer Res 2003; 9: 5642\u20135651.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2022.2535"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab864"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2799"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2798"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201900537R"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.11.010"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2016.1144004"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep40488"},{"key":"e_1_3_3_82_2","first-page":"39","article-title":"Downregulated RBM5 enhances CARM1 expression and activates the PRKACA\/GSK3\u03b2 signaling pathway through alternative splicing-coupled nonsense-mediated decay","volume":"16","author":"Zhang Y","year":"2024","unstructured":"Zhang Y, Li F, Han Z, et al. Downregulated RBM5 enhances CARM1 expression and activates the PRKACA\/GSK3\u03b2 signaling pathway through alternative splicing-coupled nonsense-mediated decay. Cancers (Basel) 2024; 16: 39.","journal-title":"Cancers (Basel)"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00623-w"},{"key":"e_1_3_3_84_2","first-page":"7035","article-title":"HnRNP-F promotes cell proliferation by regulating TPX2 in bladder cancer","volume":"11","author":"Li F","year":"2019","unstructured":"Li F, Su M, Zhao H, et al. HnRNP-F promotes cell proliferation by regulating TPX2 in bladder cancer. Am J Transl Res 2019; 11: 7035\u20137048.","journal-title":"Am J Transl Res"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.7150\/jca.50490"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14600"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12999"},{"key":"e_1_3_3_88_2","first-page":"513","article-title":"Impact of cyclin D1 and heterogeneous nuclear ribonucleoprotein-K (HnRNP-K) on urinary bladder carcinogenesis","volume":"19","author":"Aboushousha T","year":"2018","unstructured":"Aboushousha T, Hammam O, Helal N, et al. Impact of cyclin D1 and heterogeneous nuclear ribonucleoprotein-K (HnRNP-K) on urinary bladder carcinogenesis. Asian Pac J Cancer Prev 2018; 19: 513\u2013519.","journal-title":"Asian Pac J Cancer Prev"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112909"},{"key":"e_1_3_3_90_2","first-page":"5501","article-title":"Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder","volume":"9","author":"Koga F","year":"2003","unstructured":"Koga F, Kawakami S, Fujii Y, et al. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res Off J Am Assoc Cancer Res 2003; 9: 5501\u20135507.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64396-9"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M303969200"},{"key":"e_1_3_3_93_2","first-page":"7056","article-title":"An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene","volume":"63","author":"Lu F","year":"2003","unstructured":"Lu F, Gladden AB, Diehl JA. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 2003; 63: 7056\u20137061.","journal-title":"Cancer Res"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.26"},{"key":"e_1_3_3_95_2","first-page":"8108","article-title":"FGFR3 And TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder","volume":"63","author":"Bakkar AA","year":"2003","unstructured":"Bakkar AA, Wallerand H, Radvanyi F, et al. FGFR3 And TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder. Cancer Res 2003; 63: 8108\u20138112.","journal-title":"Cancer Res"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.4111\/icu.2016.57.S1.S60"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0744"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.1875"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/383509"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10496"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041150"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-017-0090-y"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-13-17"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01666-z"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01517-9"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2011.12.035"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.06.017"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI130892"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.02.019"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021776"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1964252"},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1161273"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M601252200"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36456-3"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40908"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5546612"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32679"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.90305.2008"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01896-x"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06547-7"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2019.118550"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2513"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-021-00252-x"},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.01.041"},{"key":"e_1_3_3_125_2","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.12.12.18703"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12965"},{"key":"e_1_3_3_127_2","article-title":"Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway","volume":"14","author":"Zhu Q","year":"2018","unstructured":"Zhu Q, Hong B, Zhang L, et al. Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway. J Cancer Res Ther 2018; 14: S616.","journal-title":"J Cancer Res Ther"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.74546"},{"key":"e_1_3_3_129_2","first-page":"317","article-title":"Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder","volume":"25","author":"Das K","year":"2007","unstructured":"Das K, Zhao Y, Sugiono M, et al. Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder. Urol Oncol Semin Orig Investig 2007; 25: 317\u2013321.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"e_1_3_3_130_2","first-page":"10","article-title":"Expression of vascular endothelial growth factor isoforms and platelet-derived endothelial cell growth factor in bladder cancer","volume":"6","author":"Li NC","year":"2001","unstructured":"Li NC, Kanda K, Fukumori T, et al. Expression of vascular endothelial growth factor isoforms and platelet-derived endothelial cell growth factor in bladder cancer. Urol Oncol Semin Orig Investig 2001; 6: 10\u201315.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"e_1_3_3_131_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes9020098"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2021.5037"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.666863"},{"key":"e_1_3_3_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2022.02.020"},{"key":"e_1_3_3_135_2","first-page":"41","article-title":"HNRNPL Induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1\/PKM2 pathway","volume":"42","author":"Lv J","year":"2023","unstructured":"Lv J, Li K, Yu H, et al. HNRNPL Induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1\/PKM2 pathway. J Exp Clin Cancer Res CR 2023; 42: 41.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"e_1_3_3_136_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02120-6"},{"key":"e_1_3_3_137_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102262"},{"key":"e_1_3_3_138_2","first-page":"91","article-title":"ZEB1-mediated Biogenesis of circNIPBL sustains the metastasis of bladder cancer via Wnt\/\u03b2-catenin pathway","volume":"42","author":"Li Y","year":"2023","unstructured":"Li Y, Kong Y, An M, et al. ZEB1-mediated Biogenesis of circNIPBL sustains the metastasis of bladder cancer via Wnt\/\u03b2-catenin pathway. J Exp Clin Cancer Res CR 2023; 42: 91.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"e_1_3_3_139_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-1518"},{"key":"e_1_3_3_140_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6072"},{"key":"e_1_3_3_141_2","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2270106"},{"key":"e_1_3_3_142_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2014.04.007"},{"key":"e_1_3_3_143_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1455"},{"key":"e_1_3_3_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101340"},{"key":"e_1_3_3_145_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr619"},{"key":"e_1_3_3_146_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202189109"},{"key":"e_1_3_3_147_2","first-page":"13259","article-title":"Prostate stem cell antigen variation rs2294008 associated with the risk of bladder cancer","volume":"8","author":"Li M","year":"2015","unstructured":"Li M, Yu X, Cheng L, et al. Prostate stem cell antigen variation rs2294008 associated with the risk of bladder cancer. Int J Clin Exp Med 2015; 8: 13259\u201313266.","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_3_148_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.421"},{"key":"e_1_3_3_149_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr303"},{"key":"e_1_3_3_150_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr342"},{"key":"e_1_3_3_151_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.687"},{"key":"e_1_3_3_152_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.792971"},{"key":"e_1_3_3_153_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200003000-00003"},{"key":"e_1_3_3_154_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1265"},{"key":"e_1_3_3_155_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-010-0228-6"},{"key":"e_1_3_3_156_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1531"},{"key":"e_1_3_3_157_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28898"},{"key":"e_1_3_3_158_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56947-y"},{"key":"e_1_3_3_159_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67137-1"},{"key":"e_1_3_3_160_2","first-page":"3715","article-title":"Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis","volume":"8","author":"Zhu Z","year":"2015","unstructured":"Zhu Z, Zhang J, Jiang W, et al. Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis. OncoTargets Ther 2015; 8: 3715\u20133720.","journal-title":"OncoTargets Ther"},{"key":"e_1_3_3_161_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144924"},{"key":"e_1_3_3_162_2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S152999"},{"key":"e_1_3_3_163_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep45983"},{"key":"e_1_3_3_164_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-0403"},{"key":"e_1_3_3_165_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)62438-8"},{"key":"e_1_3_3_166_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602651"},{"key":"e_1_3_3_167_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09893-7"},{"key":"e_1_3_3_168_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5259602"},{"key":"e_1_3_3_169_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-015-0730-3"},{"key":"e_1_3_3_170_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2388"},{"key":"e_1_3_3_171_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28325"},{"key":"e_1_3_3_172_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01672-1"},{"key":"e_1_3_3_173_2","doi-asserted-by":"publisher","DOI":"10.1002\/mc.21978"},{"key":"e_1_3_3_174_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs458"},{"key":"e_1_3_3_175_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2734"},{"key":"e_1_3_3_176_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.10.010"},{"key":"e_1_3_3_177_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2019.07.001"},{"key":"e_1_3_3_178_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02241-4"},{"key":"e_1_3_3_179_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02153-9"},{"key":"e_1_3_3_180_2","doi-asserted-by":"publisher","DOI":"10.1177\/147323001103900222"},{"key":"e_1_3_3_181_2","doi-asserted-by":"publisher","DOI":"10.1515\/oncologie-2023-0014"},{"key":"e_1_3_3_182_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.11.022"},{"key":"e_1_3_3_183_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111704"},{"key":"e_1_3_3_184_2","doi-asserted-by":"publisher","DOI":"10.1134\/S2079059716050129"},{"key":"e_1_3_3_185_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt589"},{"key":"e_1_3_3_186_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2800"},{"key":"e_1_3_3_187_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-015-9754-x"},{"key":"e_1_3_3_188_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-01491-2"},{"key":"e_1_3_3_189_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308849"},{"key":"e_1_3_3_190_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.003"},{"key":"e_1_3_3_191_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1283"},{"key":"e_1_3_3_192_2","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2019.1596922"},{"key":"e_1_3_3_193_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2018.03.011"},{"key":"e_1_3_3_194_2","doi-asserted-by":"crossref","unstructured":"Teng T Tsai JH Puyang X et al. Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A\u2013SF3b complex. Nat Commun 2017; 8: 15522.","DOI":"10.1038\/ncomms15522"},{"key":"e_1_3_3_195_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.286"},{"key":"e_1_3_3_196_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01686.x"},{"key":"e_1_3_3_197_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.2014311"},{"key":"e_1_3_3_198_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4493"},{"key":"e_1_3_3_199_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.966.966"},{"key":"e_1_3_3_200_2","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2019.1709134"},{"key":"e_1_3_3_201_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2021.10.004"},{"key":"e_1_3_3_202_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6606016"},{"key":"e_1_3_3_203_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702752"},{"key":"e_1_3_3_204_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1941310"},{"key":"e_1_3_3_205_2","doi-asserted-by":"publisher","DOI":"10.3233\/JND-210643"},{"key":"e_1_3_3_206_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0485"},{"key":"e_1_3_3_207_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-013-0046-5"},{"key":"e_1_3_3_208_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011222"},{"key":"e_1_3_3_209_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01328-9"},{"key":"e_1_3_3_210_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2007.18"},{"key":"e_1_3_3_211_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24081496"},{"key":"e_1_3_3_212_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0321"},{"key":"e_1_3_3_213_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-015-0625-4"},{"key":"e_1_3_3_214_2","doi-asserted-by":"publisher","DOI":"10.1021\/cb100356k"},{"key":"e_1_3_3_215_2","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-5640"},{"key":"e_1_3_3_216_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0557-y"},{"key":"e_1_3_3_217_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02240-8"},{"key":"e_1_3_3_218_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30516-8"},{"key":"e_1_3_3_219_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.07.001"},{"key":"e_1_3_3_220_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4239"},{"key":"e_1_3_3_221_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-03005-9"},{"key":"e_1_3_3_222_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17526-5"},{"key":"e_1_3_3_223_2","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2025.1002288"},{"key":"e_1_3_3_224_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01226-y"},{"key":"e_1_3_3_225_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114893"},{"key":"e_1_3_3_226_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.053"},{"key":"e_1_3_3_227_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.05.038"},{"key":"e_1_3_3_228_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-025-02623-4"},{"key":"e_1_3_3_229_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04834-9"},{"key":"e_1_3_3_230_2","first-page":"39","article-title":"The Oxford nanopore MinION: delivery of nanopore sequencing to the genomics community","volume":"17","author":"Jain M","year":"2016","unstructured":"Jain M, Olsen HE, Paten B, et al. The Oxford nanopore MinION: delivery of nanopore sequencing to the genomics community. Genome Biol 2016; 17: 39.","journal-title":"Genome Biol"}],"container-title":["Bladder Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23523735251389276","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23523735251389276","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23523735251389276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:23:04Z","timestamp":1777382584000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23523735251389276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":229,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1177\/23523735251389276"],"URL":"https:\/\/doi.org\/10.1177\/23523735251389276","relation":{},"ISSN":["2352-3727","2352-3735"],"issn-type":[{"value":"2352-3727","type":"print"},{"value":"2352-3735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"article-number":"23523735251389276"}}